Humacyte, Inc. - COM (HUMA)

Historical Holders from Q3 2021 to Q3 2025

Symbol
HUMA on Nasdaq
Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
45,852,231
Holdings value
$79,792,130
% of all portfolios
0%
Number of holders
139
Number of buys
51
Number of sells
-75
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Humacyte, Inc. - COM (HUMA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 45,852,231 $79,792,130 -$20,565,959 $1.74 139
2025 Q2 56,964,566 $119,040,607 -$1,729,485 $2.09 155
2025 Q1 60,715,449 $103,532,553 +$24,167,009 $1.7 162
2024 Q4 42,106,165 $212,715,890 +$30,515,138 $5.05 161
2024 Q3 35,792,230 $194,660,626 +$23,757,191 $5.44 143
2024 Q2 31,200,014 $149,783,918 +$47,689,218 $4.8 120
2024 Q1 23,275,197 $72,382,833 +$17,071,734 $3.11 95
2023 Q4 17,820,871 $50,656,070 +$3,312,296 $2.84 87
2023 Q3 16,610,977 $48,671,458 +$5,715,520 $2.93 83
2023 Q2 14,729,897 $42,225,781 +$7,517,496 $2.86 75
2023 Q1 12,062,725 $37,417,372 +$154,698 $3.09 68
2022 Q4 11,918,522 $25,143,027 -$3,006,763 $2.11 71
2022 Q3 11,840,854 $38,602,556 -$5,136,200 $3.26 68
2022 Q2 13,437,579 $43,130,190 +$8,049,232 $3.21 75
2022 Q1 10,487,756 $73,993,016 +$6,152,869 $7.06 69
2021 Q4 9,522,696 $69,016,600 +$7,310,797 $7.25 58
2021 Q3 4,907,194 $56,957,000 +$56,946,000 $11.61 31